KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Supernus Pharmaceuticals (SUPN) over the last 15 years, with Q3 2025 value amounting to $742.6 million.

  • Supernus Pharmaceuticals' Goodwill & Intangibles rose 1299.29% to $742.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $742.6 million, marking a year-over-year increase of 1299.29%. This contributed to the annual value of $638.9 million for FY2024, which is 1087.68% down from last year.
  • According to the latest figures from Q3 2025, Supernus Pharmaceuticals' Goodwill & Intangibles is $742.6 million, which was up 1299.29% from $598.3 million recorded in Q2 2025.
  • Supernus Pharmaceuticals' 5-year Goodwill & Intangibles high stood at $902.2 million for Q4 2021, and its period low was $424.6 million during Q3 2021.
  • For the 5-year period, Supernus Pharmaceuticals' Goodwill & Intangibles averaged around $698.7 million, with its median value being $716.9 million (2023).
  • Over the last 5 years, Supernus Pharmaceuticals' Goodwill & Intangibles had its largest YoY gain of 175184.7% in 2021, and its largest YoY loss of 1359.89% in 2021.
  • Over the past 5 years, Supernus Pharmaceuticals' Goodwill & Intangibles (Quarter) stood at $902.2 million in 2021, then decreased by 9.17% to $819.5 million in 2022, then fell by 12.52% to $716.9 million in 2023, then decreased by 10.88% to $638.9 million in 2024, then increased by 16.22% to $742.6 million in 2025.
  • Its Goodwill & Intangibles was $742.6 million in Q3 2025, compared to $598.3 million in Q2 2025 and $619.1 million in Q1 2025.